CGT Global News

Featured Post

CGT Global Attends Advanced Therapies USA 2024 to Support Cell and Gene Therapy Innovation

By CGT Global | November 12, 2024 | Comments Off on CGT Global Attends Advanced Therapies USA 2024 to Support Cell and Gene Therapy Innovation

CGT Global’s Cate Spears and Eliona Kola attend Advanced Therapies USA 2024, engaging with industry leaders to advance cell and gene therapy innovation. Attending Advanced Therapies USA is a valuable opportunity to engage with global leaders…

Read More

EIN Presswire: CGT Global Receives Approval Aiding Scientists in Discovering Life-Saving Cures

By aaron | June 24, 2024 | Comments Off on EIN Presswire: CGT Global Receives Approval Aiding Scientists in Discovering Life-Saving Cures

CGT Global, a leading Contract Research Organization (CRO) & biotech manufacturer announced approval to provide disease state leukopaks to researchers worldwide FOLSOM, CALIFORNIA, UNITED STATES, June 11, 2024 /EINPresswire.com/ — CGT Global, a leading international Contract…

Read More

EIN Presswire: CGT Global and Austin Financial Partner to Drive Momentum for Cutting-Edge Cell Therapy Treatments and Cures

By aaron | June 24, 2024 | Comments Off on EIN Presswire: CGT Global and Austin Financial Partner to Drive Momentum for Cutting-Edge Cell Therapy Treatments and Cures

CGT Global, leader in human cell collection, partners with Austin Financial Services to expedite cell & gene therapy research for life-threatening conditions. FOLSOM, CALIFORNIA, USA, March 20, 2024 /EINPresswire.com/ — A world leader in human cell…

Read More

EIN Presswire: CGT Global Selected as Strategic Partner to Expand Cell and Gene Therapies Across the United States

By aaron | June 24, 2024 | Comments Off on EIN Presswire: CGT Global Selected as Strategic Partner to Expand Cell and Gene Therapies Across the United States

FOLSOM, CA, UNITED STATES, December 6, 2023 /EINPresswire.com/ — CGT GLOBAL, a company dedicated to expanding access and scalability of cell and gene therapies, has announced a major collaboration with global company Orgenesis (NASDAQ: ORGS)…

Read More